Bure Equity AB

BURE

SE0000195810

Investment Holding Companies

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-06-28 EDT			5-day change	1st Jan Change
357 ^SEK	-0.11%		-2.19%	+24.91%

06-24	Bure Equity AB (OM:BURE) signed an agreement to acquire 12% stake in Mentimeter AB from AlfvÉN & Didrikson Invest Ab for SEK 450 million.	CI
05-13	Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Bure Equity Appoints Henrik Blomquist as its Chief Executive Officer

February 20, 2014 at 01:19 pm

At its ordinary board meeting held on February 20, 2014, the board of directors of Bure Equity has appointed Henrik Blomquist as Chief Executive Officer. Henrik Blomquist is Acting CEO of the company since April 2013 and prior to that Executive Vice President since 2010.

Latest news about Bure Equity AB

Bure Equity AB (OM:BURE) signed an agreement to acquire 12% stake in Mentimeter AB from AlfvÉN & Didrikson Invest Ab for SEK 450 million.	06-23	CI
Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Bure Equity AB Approves Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024	05-07	CI
Bure Equity AB Proposes Ordinary Dividend for the 2023 Financial Year, Payable on 15 May 2024	02-22	CI
Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-22	CI
Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-22	CI
Bure Equity AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
An Unknown buyer acquired 3.8% stake in Mycronic AB (OM:MYCR) from Bure Equity AB (OM:BURE) for SEK 870 million.	11-06	CI
Bure Equity AB Announces Appointment of Nominating Committee	23-09-29	CI
Yubico AB completed the acquisition of ACQ Bure AB (OM:ACQ SPAC) from a group of shareholders in a reverse merger transaction.	23-09-19	CI
Bure Equity AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Vitrolife AB (publ) : A pioneer in in vitro fertilization	23-07-26
Bure Equity AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Bure Equity AB Approves Ordinary Cash Dividend, Payable on 10 May 2023	23-05-03	CI
Yubico AB agreed to acquire ACQ Bure AB (OM:ACQ SPAC) from a group of shareholders for SEK 8.2 billion in a reverse merger transaction.	23-04-18	CI
Bure Equity AB Proposes Dividend for the Financial Year 2022, Payable on 10 May 2023	23-03-30	CI
Bure Equity AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-23	CI
Bure Equity AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Bure Equity AB Proposes Ordinary Dividend for 2022	23-02-23	CI
Bure Equity AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Bure Equity AB Announces Nominating Committee Appointments	22-09-28	CI
Bure Equity AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-19	CI
Mentice AB announced that it has received SEK 60 million in funding from Bure Equity AB, AP Fonden 4, Handelsbanken Fonder AB, Teknik Innovation Norden Fonder AB	22-06-08	CI
Bure Equity AB Approves Cash Dividend for the Year 2021	22-05-03	CI
Bure Equity AB Approves Appointment of Birgitta Stymne Göransson as Board Member	22-05-03	CI

Chart Bure Equity AB

Duration

Period

More charts

Company Profile

Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.

Sector

Investment Holding Companies

Calendar

2024-08-16 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Holding Companies

	1st Jan change	Capi.
BURE EQUITY AB	+24.91%	2.5B
INVESTOR AB	+24.28%	83.58B
KOÇ HOLDING	+59.94%	17.55B
INVESTMENT AB LATOUR	+9.11%	17.26B
AB INDUSTRIVÄRDEN	+9.64%	14.64B
L E LUNDBERGFÖRETAGEN AB	-4.41%	12.26B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+11.19%	11.39B
HAL TRUST	-0.70%	10.94B
MERITZ FINANCIAL GROUP INC.	+33.84%	10.57B
SK SQUARE CO., LTD.	+90.11%	9.77B